Details for New Drug Application (NDA): 208931
✉ Email this page to a colleague
The generic ingredient in LORATADINE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 208931
Tradename: | LORATADINE |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | loratadine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 208931
Suppliers and Packaging for NDA: 208931
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LORATADINE | loratadine | SYRUP;ORAL | 208931 | ANDA | Better Living Brands LLC | 21130-042 | 21130-042-24 | 1 BOTTLE in 1 CARTON (21130-042-24) / 120 mL in 1 BOTTLE |
LORATADINE | loratadine | SYRUP;ORAL | 208931 | ANDA | KROGER COMPANY | 30142-062 | 30142-062-24 | 1 BOTTLE in 1 CARTON (30142-062-24) / 120 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SYRUP;ORAL | Strength | 1MG/ML | ||||
Approval Date: | Jun 29, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription